Singleron Biotechnologies. (9/11/24). "Press Release: Singleron Launches New All-in-One sCelLiVE Tissue Dissociation Kit for Skin". Cologne.

	Organisation	Singleron Biotechnologies GmbH
	Group	Singleron (Group)
	Product	sCelLiVE® Tissue Dissociation Kit (Skin) (sCelLiVE Skin)
	Product 2	PythoN® automated dissociation equipment

Singleron announced the launch of sCelLiVE® Tissue Dissociation Kit (Skin) (sCelLiVE Skin), a new all-in-one solution for human and mouse skin tissue. The new product significantly reduces processing time while preserving cell viability and features, enabling high-quality downstream analysis, such as single cell sequencing.

Skin is a complex tissue that is difficult and time-consuming to dissociate. sCelLiVE Skin addresses these challenges with an automated workflow that dissociates whole skin without the need to separate the dermis and epidermis layers. It reduces the total processing time from the current 3 hours to 2 days down to just 60–120 minutes.

In addition to its speed, sCelLiVE Skin consistently produces single cell suspensions with over 90% viability while maintaining the proportions of all major cell populations. This preservation of cell viability and characteristics is critical for the quality of downstream analysis.

The kit is compatible with tissue samples ranging from 10 mg to 300 mg, accommodating various research needs, from small needle biopsies to larger tissue samples.

sCelLiVE Skin is designed with convenience in mind. The single working solution requires no reagent mixing. The reagent kit is optimized for Singleron’s automated dissociation equipment, PythoN® and PythoN Junior™, for a streamlined, hands-free workflow.

Beyond single cell analysis, sCelLiVE Skin supports various downstream applications, including cell and organoid culture and flow cytometry. It is suited for research into skin cancers, autoimmune diseases, skin aging, and the testing of cosmetics and pharmaceutical products.

sCelLiVE Skin complements Singleron’s extensive tissue preservation and dissociation portfolio, validated across over 1,000 sample types. It integrates seamlessly with Singleron’s automation equipment, PythoN and PythoN Junior, and complements the company’s end-to-end single cell analysis products and services.

About Singleron

Singleron Biotechnologies advances precision medicine and human health through pioneering single cell multi-omics solutions. Its current product portfolio includes high throughput instruments for automated single cell processing and tissue dissociation, reagents, bioinformatics software, and a comprehensive single cell knowledgebase.

Founded in 2018, Singleron operates globally with offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in more than 3,000 laboratories in hospitals, research institutes, and pharmaceutical companies.

Record changed: 2024-09-12